Ann LaCasce, MD, Oncology, Boston, MA, Dana-Farber Cancer Institute

AnnLaCasceMD

Oncology Boston, MA

Hematologic Oncology

Associate Professor

Dr. LaCasce is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. LaCasce's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalFellowship, Hematology/Oncology, 1999 - 2002
  • Brigham and Women's Hospital
    Brigham and Women's HospitalInternship, Internal Medicine, 1996 - 1997
  • Tufts University School of Medicine
    Tufts University School of MedicineClass of 1996

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1998 - 2022
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Current Considerations in AYA Hodgkin Lymphoma  
    Jennifer L Crombie, Ann S LaCasce, British Journal of Haematology
  • CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma  
    Mark P Chao, Sonali M Smith, Ranjana Advani, Ian Flinn, Ravindra Majeti, Nancy L Bartlett, Leslie Popplewell, Justin Kline, Nilanjan Ghosh, Ann LaCasce, The New England Journal of Medicine

Abstracts/Posters

  • Brentuximab Vedotin and Nivolumab for Relapsed or Refractory Classic Hodgkin Lymphoma: Long-Term Follow-up Results from the Single-Arm Phase 1/2 Study
    Ann S. LaCasce, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Preliminary Safety and Efficacy Results from a Phase 2 Study of Acalabrutinib, Venetoclax and Obinutuzumab in Patients with Previously Untreated Chronic Lymphocytic Le...
    Ann S. LaCasce, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/7/2019

Lectures

  • How to Prepare Fellows for the Transition to Academia 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019
  • Training Program DirectorsÍ Workshop 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Training Program DirectorsÍ Workshop 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Join now to see all

Other

Press Mentions

  • Researcher Highlights the Need for Curative Approach to Mantle Cell Lymphoma Treatment
    Researcher Highlights the Need for Curative Approach to Mantle Cell Lymphoma TreatmentMay 20th, 2019
  • Education Session to Bridge the Adolescent, Adult Divide in Hodgkin Lymphoma Treatment
    Education Session to Bridge the Adolescent, Adult Divide in Hodgkin Lymphoma TreatmentMay 26th, 2016
  • Volume 15 ”¢ Issue 2 ”¢ Spring 2017
    Volume 15 Ӣ Issue 2 Ӣ Spring 2017February 19th, 2018

Hospital Affiliations